newsfilter
← Latest News
GlobeNewswire·

Iterum Therapeutics Regains Full Nasdaq Compliance

DUBLIN and CHICAGO, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (NASDAQ:ITRM), (the Company), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by